A detailed history of Prudential Financial Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Prudential Financial Inc holds 157,064 shares of ENTA stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
157,064
Previous 157,064 -0.0%
Holding current value
$1.59 Million
Previous $2.04 Million 20.08%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$11.43 - $17.02 $173,736 - $258,704
-15,200 Reduced 8.82%
157,064 $2.04 Million
Q1 2024

May 14, 2024

SELL
$10.08 - $17.46 $214,704 - $371,898
-21,300 Reduced 11.0%
172,264 $3.01 Million
Q4 2023

Feb 13, 2024

BUY
$8.18 - $10.78 $110,430 - $145,530
13,500 Added 7.5%
193,564 $1.82 Million
Q3 2023

Nov 13, 2023

BUY
$11.09 - $22.13 $1.64 Million - $3.27 Million
147,812 Added 458.3%
180,064 $2.01 Million
Q2 2023

Aug 11, 2023

SELL
$20.68 - $39.85 $222,247 - $428,267
-10,747 Reduced 24.99%
32,252 $690,000
Q1 2023

May 12, 2023

BUY
$38.82 - $54.59 $902,565 - $1.27 Million
23,250 Added 117.73%
42,999 $1.74 Million
Q3 2022

Nov 04, 2022

BUY
$48.29 - $71.27 $41,529 - $61,292
860 Added 4.55%
19,749 $1.02 Million
Q2 2022

Aug 15, 2022

SELL
$38.13 - $76.93 $15,442 - $31,156
-405 Reduced 2.1%
18,889 $893,000
Q1 2022

May 13, 2022

BUY
$56.06 - $74.11 $7,792 - $10,301
139 Added 0.73%
19,294 $1.37 Million
Q4 2021

Feb 14, 2022

SELL
$60.19 - $97.37 $15,348 - $24,829
-255 Reduced 1.31%
19,155 $1.43 Million
Q3 2021

Nov 15, 2021

SELL
$41.02 - $58.65 $5,332 - $7,624
-130 Reduced 0.67%
19,410 $1.1 Million
Q2 2021

Aug 16, 2021

SELL
$43.76 - $53.11 $44,022 - $53,428
-1,006 Reduced 4.9%
19,540 $860,000
Q1 2021

May 12, 2021

SELL
$41.69 - $54.95 $15,133 - $19,946
-363 Reduced 1.74%
20,546 $1.01 Million
Q4 2020

Feb 16, 2021

SELL
$41.16 - $47.47 $108,662 - $125,320
-2,640 Reduced 11.21%
20,909 $880,000
Q3 2020

Nov 16, 2020

BUY
$43.36 - $53.53 $97,429 - $120,281
2,247 Added 10.55%
23,549 $1.08 Million
Q2 2020

Aug 12, 2020

SELL
$46.37 - $57.58 $197,721 - $245,521
-4,264 Reduced 16.68%
21,302 $1.07 Million
Q1 2020

May 12, 2020

SELL
$40.22 - $62.0 $2.02 Million - $3.11 Million
-50,141 Reduced 66.23%
25,566 $1.31 Million
Q4 2019

Feb 11, 2020

BUY
$57.95 - $66.61 $2.46 Million - $2.82 Million
42,377 Added 127.14%
75,707 $4.68 Million
Q3 2019

Nov 13, 2019

SELL
$60.08 - $88.17 $20,066 - $29,448
-334 Reduced 0.99%
33,330 $2 Million
Q2 2019

Aug 08, 2019

BUY
$81.3 - $97.35 $52,845 - $63,277
650 Added 1.97%
33,664 $0
Q1 2019

May 15, 2019

SELL
$69.08 - $105.66 $429,332 - $656,676
-6,215 Reduced 15.84%
33,014 $0
Q4 2018

Feb 07, 2019

SELL
$65.41 - $84.65 $11.8 Million - $15.3 Million
-180,586 Reduced 82.15%
39,229 $2.78 Million
Q3 2018

Nov 07, 2018

SELL
$85.46 - $126.37 $7.07 Million - $10.5 Million
-82,772 Reduced 27.35%
219,815 $0
Q2 2018

Aug 13, 2018

BUY
$81.85 - $120.51 $6.99 Million - $10.3 Million
85,397 Added 39.32%
302,587 $0
Q1 2018

May 04, 2018

BUY
$57.91 - $92.15 $7.21 Million - $11.5 Million
124,458 Added 134.21%
217,190 $0
Q4 2017

Feb 13, 2018

BUY
$45.65 - $59.37 $2.11 Million - $2.74 Million
46,135 Added 99.01%
92,732 $5.44 Million
Q3 2017

Nov 02, 2017

BUY
$37.91 - $46.8 $1.77 Million - $2.18 Million
46,597
46,597 $2.18 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $210M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.